[Featured Stock] PBPharma Plummets on First Day of Listing
[Asia Economy Reporter Jang Hyowon] Prestige BioPharma (PBP Pharma) is experiencing a sharp decline on its first day of listing.
As of 9:13 AM on the 5th, PBP Pharma is trading at 25,050 KRW, down 13.02% from the opening price. This is a 21.72% decrease compared to the public offering price of 32,000 KRW.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "To Get Revenge on Ex-Girlfriend" US McDonald's Manager Spits on French Fries
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Prestige BioPharma, established in 2015 and based in Singapore, is a pharmaceutical company developing biosimilars (biopharmaceutical generics) and antibody drugs.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
